Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Bai, Bingke ^a,c,d   Hu, Qinxue ^a   Hu, Hui ^a   Zhou, Peng ^a,b   Shi, Zhengli ^a   Meng, Jin ^a,b   Lu, Baojing ^a,b   Huang, Yi ^a   Mao, Panyong ^c   Wang, Hanzhong ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Institute of Infectious Diseases   (China)

^d Chinese People's Liberation Army Postgraduate Medical School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MEMBRANE PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS SPIKE PROTEIN; CYTOKINE;

ANTIBODY RESPONSE; ARTICLE; BACULOVIRUS; BAT; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGOLD LABELING; INOCULATION; INSECT CELL; LYMPHOCYTE DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TH1 CELL; TH2 CELL; UPREGULATION; VIRUS ISOLATION; VIRUS LIKE AGENT; VIRUS RECOMBINANT; WESTERN BLOTTING; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; IMMUNE SYSTEM; METABOLISM; MONONUCLEAR CELL; PHENOTYPE; PLASMID; VIROLOGY;

CORONAVIRUS; HEXAPODA; MUS; SARS CORONAVIRUS;

BACULOVIRIDAE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; PHENOTYPE; PLASMIDS; SARS VIRUS; TH1 CELLS;

EID: 49949116379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002685     Document Type: Article

References (49)

1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348: 1967-1976.
2. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doomurn GJ, et al. (2003) Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 423: 240.
3. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N. Engl.J. Med. 348: 953-966.
4. Peiris JS, Lai ST, Poon 11, Guan Y, Yam LY, et al. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361: 1319-1325.
5. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, et al. (2003) Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348: 1995-2005.
6. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson YS, et al. (2003) The Genome sequence of the SARS-associated coronavirus. Science. 300: 1399-1404.
7. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, et al. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. pp 1394-1399.
8. Babcock GJ, Esshaki DJ, Jr Thomas WD, Ambrosino DM (2004) Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor. J. Virol. 78: 4552-4560.
9. He Y, Li J, Heck S, Lustigman S, Jiang S (2006) Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. J. Virol. 80: 5757-5767.
10. Li W, Moore MJ, Vasiheva N, Sui J, Wong SK, et al. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426: 450-454.
11. Buchholz UJ, Bukreyev A, Yang L, Landrande EW, Murphy BR, et al. (2004) Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A. 101: 9804-9809.
12. Baudoux P, Carrat C, Besnardeau L, Charley B, Laude H (1998) Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes. J. Virol. 72: 863&-8643.
13. Bos EC, Luytjes W, van der Meulen HV, Koerten HK, Spaan WJ (1996) The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology. 218: 52-60.
14. Corse E, Machamer CE (2000) Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles, J. Virol. 74: 4319-4326.
15. Ho Y, Lin PH, Liu CY, Lee SP, Chao YC (2004) Assembly of human severe acute respiratory syndrome coronavirus-like particles. Biochem Biophys Res Commun. 318: 833-838.
16. Vennema H, Godeke GJ, Rossen JW, Voorhout WF, Horzinek MC, et al. (1996) Nucleocapsid independent assembly of coronavirus-like particles by coexpression of viral envelope protein genes. EMBO J. 15: 2020-2028.
17. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, et al. (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 302: 276-278.
18. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, et al. (2005) Severe acute respiratory syndrome coronavirus-like viruis in Chinese horseshoe bats. Proc Natl Acad Sci U S A. 102: 14040-14045.
19. Li WD, Shi ZI, Yu M, Ren WZ, Smith C, et al. (2005) Bats are natural reservoirs of SARS-like coronaviruses. Science. 310: 676-679.
20. Ren WZ, Li WD, Yu M, Hao P, Zhang Y, et al. (2006) Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J Gen Virol. 87: 3355-3359.
21. Kuo I, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ (2000) Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol. 74: 1393-1406.
22. Noad R, Roy P (2003) Virus-like particles as immunogens. Trends Microbiol. 11: 438-444.
23. Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, et al. (2003) Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection. Proc Natl Acad Sci U S A. 100: 6753-6758.
24. Paliard X, Liu Y, Wagner R, Wolf H, Baenziger J, et al. (2000) Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res Hum Retroviruses. 16: 273-282.
25. Schirmbeck R, Bohm W, Reimann J (1996) Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology. 39: 111-119.
26. Bosio CM, Moore BD, Warrield KL, Ruthel G, Mohamadzadeh M, et al. (2004) Ebola and Marburg virus-like particles activate human mycloid dendritic cells. Virology. 326: 280-287.
27. Buonagurro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, et al. (2006) Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J. Virol. 80: 9134-9143.
28. Ye L, Lin J, Sun Y, Bennouna S, Lo M, et al. (2006) Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology. 351: 260-270.
29. Lu XY, Chen Y, Bai BK, Hu H, Tao L, et al. (2007) Immune Responses Against SARS CoV Induced by Virus-Like Particles in Mice. Immunology. 122: 496-502.
30. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104: 487-501.
31. Liu YJ (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 106: 259-262.
32. Zhao P, Ke JS, Quit ZI, Ren H, Zhao LJ, et al. (2004) DNA vaccine of SARS-Cov S gene induces antibody response in mice. Acta Biochim Biophys Sin (Shanghai). 36: 37-41.
33. Bisht H, Roberts A, Vogel I, Bukreyev A, Collins PL, et al. (2004) Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Arad Sci U S A. 101: 6641-6646.
34. Yang ZY, Huang Y, Ganesh L, Leung K, Kong WP, et al. (2004) PH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN.J Virol. 78: 5642-5650.
35. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, et al. (1998) Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol. 72: 9628-9636.
36. Sanchez CM, Izeta A, Sanchez-Morgado JM, Alonso S, Sola I, et al. (1999) Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.J Virol. 73: 7607-7618.
37. Cui W, Fan Y, Wu W, Zhang F, Wang JY, et al. (2003) Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome. Clin Inlect. Dis. 37: 857-859.
38. Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, et al. (2005) Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus.J. Infect. Dis. 191: 193-197.
39. Nakajima N, Asahi-Ozaki Y, Nagatat N, Sato Y, Dizon F, et al. (2003) SARS coronavirus-infected cells in lung detected by new in situ hybridization technique.Jpn J Infect Dis 56: 139-141.
40. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature. 392: 245-252.
41. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 9: 10-16.
42. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
43. Tseng CT, Perrone LA, Zhu H, Makino S, Peters CJ (2005) Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 174: 7977-7985.
44. Spiegel M, Schneider K, Weber F, Weidmann M, Hutfert FT (2006) Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol. 87: 1953-1960.
45. Hsueh PR, Chen PJ, Hsiao CH, Yeh SH, Cheng WC, et al. (2004) Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis. 10: 489-493.
46. Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, et al. (2003) High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med. 168: 1449 1456.
47. Harris R, Polayers D (1997) A new baculovirus expression vector for the simultaneous expression of two heterologous proteins in the same insect cell. Focus. 19: 72-74.
48. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage, colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179: 1109-1118.
49. Jacobs DM, Morrison DC (1977) Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B.J. Immunol. 118: 21-27.